Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.

Goyal RK, Srivastava D, Lessnau KD.

Pharmacotherapy. 2009 May;29(5):608-12. doi: 10.1592/phco.29.5.608. Review.

PMID:
19397467
2.
3.

Clopidogrel-induced hepatotoxicity and fever.

Ng JA, Goldberg N, Tafreshi MJ.

Pharmacotherapy. 2006 Jul;26(7):1023-6.

PMID:
16878371
4.

Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.

Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA.

Ann Pharmacother. 2006 Jun;40(6):1204-7. Epub 2006 May 9.

PMID:
16684808
5.

Clopidogrel desensitization: case report and review of published protocols.

Owen P, Garner J, Hergott L, Page RL 2nd.

Pharmacotherapy. 2008 Feb;28(2):259-70. doi: 10.1592/phco.28.2.259. Review.

PMID:
18225971
6.

Hydralazine-induced cholestatic hepatitis.

Hassan A, Hammad R, Cucco R, Niranjan S.

Am J Ther. 2009 Jul-Aug;16(4):371-3. doi: 10.1097/MJT.0b013e31817fde85.

PMID:
19092641
7.

Clopidogrel-induced hepatotoxicity after percutaneous coronary stenting.

Chau TN, Yim KF, Mok NS, Chan WK, Leung VK, Leung MF, Lai ST.

Hong Kong Med J. 2005 Oct;11(5):414-6.

8.

[Late-appearing cholestatic icterus after a month of treatment with ticlopidine].

Placci A, Melandri G, Cecilioni L, Valgimigli M, Bolondi L, Branzi A.

Ital Heart J Suppl. 2001 Nov;2(11):1240-2. Italian.

PMID:
11775418
9.

Clopidogrel-induced mixed hepatocellular and cholestatic liver injury.

Willens HJ.

Am J Ther. 2000 Sep;7(5):317-8.

PMID:
11317178
10.

Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).

Rangé G, Yayehd K, Belle L, Thuaire C, Richard P, Cazaux P, Barbou F, Köning R, Chassaing S, Teiger E, Berthier R, Decomis MP, Claudel JP, Delarche N, Brunel P, De Poli F, Dupouy P, Beygui F, Albert F, Collet JP, Montalescot G; VERIFRENCHY investigators.

Arch Cardiovasc Dis. 2014 Apr;107(4):225-35. doi: 10.1016/j.acvd.2014.03.004. Epub 2014 Apr 29.

11.

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KA, Yusuf S; CURRENT-OASIS 7 trial investigators.

Lancet. 2010 Oct 9;376(9748):1233-43. doi: 10.1016/S0140-6736(10)61088-4.

PMID:
20817281
12.

Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting.

Anselmino M, Moretti C, Ravera L, Sheiban I.

Minerva Cardioangiol. 2010 Apr;58(2):277-80.

PMID:
20440256
13.

Ticlopidine-induced cholestatic hepatitis.

Skurnik YD, Tcherniak A, Edlan K, Sthoeger Z.

Ann Pharmacother. 2003 Mar;37(3):371-5.

PMID:
12639165
14.

Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).

Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.

JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.

15.
16.

Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.

Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.

Am Heart J. 2000 Sep;140(3):483-91.

PMID:
10966552
17.

[Ticlopidine-induced cholestasis].

Meyer MI, Kuhn M, Bühler H, Bertschinger P.

Schweiz Med Wochenschr. 1999 Oct 2;129(39):1405-9. German.

PMID:
10542998
18.

Ticlopidine-induced severe cholestatic hepatitis.

Wu MS, Chan P, Lien GS, Cheng YS, Pan S.

Zhonghua Yi Xue Za Zhi (Taipei). 2000 Aug;63(8):663-6.

PMID:
10969455
19.

Fatal liver injury associated with clopidogrel.

Kastalli S, El Aïdli S, Zaïem A, ben Abdallah H, Daghfous R.

Fundam Clin Pharmacol. 2010 Aug;24(4):433-5. doi: 10.1111/j.1472-8206.2009.00791.x. Epub 2009 Nov 5.

PMID:
19895648
20.

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM; TRITON-TIMI 38 Investigators.

Lancet. 2008 Apr 19;371(9621):1353-63. doi: 10.1016/S0140-6736(08)60422-5. Epub 2008 Apr 2.

PMID:
18377975

Supplemental Content

Support Center